Similar articles for PMID: 1378308

Year	Number of Results
1977	1
1981	3
1982	4
1983	2
1984	7
1985	7
1986	10
1987	3
1988	7
1989	4
1990	6
1991	3
1992	4
1993	7
1994	4
1995	2
1996	3
1997	2
1998	5
1999	2
2000	5
2001	1
2002	2
2003	3
2004	2
2006	1
2007	1
2016	1
2018	1
2019	1
2020	2
2022	2

1

Serum aluminum levels as a reflection of renal osteodystrophy status and bone surface aluminum staining.

Hodsman AB, Steer BM. Hodsman AB, et al. J Am Soc Nephrol. 1992 Feb;2(8):1318-27. doi: 10.1681/ASN.V281318. J Am Soc Nephrol. 1992. PMID: 1378308 Free article.

2

Staining of bone for aluminum: use of acid solochrome azurine.

Kaye M, Hodsman AB, Malynowsky L. Kaye M, et al. Kidney Int. 1990 Apr;37(4):1142-7. doi: 10.1038/ki.1990.97. Kidney Int. 1990. PMID: 1692893 Free article.

3

Aluminum deposition in the bone of patients with chronic renal failure--detection of aluminum accumulation without signs of aluminum toxicity in bone using acid solochrome azurine.

Rüster M, Abendroth K, Lehmann G, Stein G. Rüster M, et al. Clin Nephrol. 2002 Oct;58(4):305-12. doi: 10.5414/cnp58305. Clin Nephrol. 2002. PMID: 12400847

4

Detection of subtle aluminum-related renal osteodystrophy.

Romanski SA, McCarthy JT, Kluge K, Fitzpatrick LA. Romanski SA, et al. Mayo Clin Proc. 1993 May;68(5):419-26. doi: 10.1016/s0025-6196(12)60186-4. Mayo Clin Proc. 1993. PMID: 7683072

5

Histochemical staining of bone aluminum: comparison of aluminon and acid solochrome azurine and their correlation with bone aluminum content.

dos Reis LM, Tzanno-Martins C, Jorgetti V. dos Reis LM, et al. Rev Hosp Clin Fac Med Sao Paulo. 1997 Jul-Aug;52(4):171-4. Rev Hosp Clin Fac Med Sao Paulo. 1997. PMID: 9567366

6

[Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].

Jarava C, Armas JR, Palma A. Jarava C, et al. Nefrologia. 2001 Mar-Apr;21(2):174-81. Nefrologia. 2001. PMID: 11464651 Free article. Spanish.

7

Staining of bone aluminium: comparison between aluminon and solochrome azurine and their correlation with bone aluminium content.

Fernández-Martín JL, Menéndez P, Acuña G, Canteros A, Gómez C, Cannata JB. Fernández-Martín JL, et al. Nephrol Dial Transplant. 1996;11 Suppl 3:80-5. doi: 10.1093/ndt/11.supp3.80. Nephrol Dial Transplant. 1996. PMID: 8840315

8

Renal osteodystrophy in dialysis patients: diagnosis and treatment.

Fournier A, Oprisiu R, Hottelart C, Yverneau PH, Ghazali A, Atik A, Hedri H, Said S, Sechet A, Rasolombololona M, Abighanem O, Sarraj A, El Esper N, Moriniere P, Boudailliez B, Westeel PF, Achard JM, Pruna A. Fournier A, et al. Artif Organs. 1998 Jul;22(7):530-57. doi: 10.1046/j.1525-1594.1998.06198.x. Artif Organs. 1998. PMID: 9684690 Review.

9

Renal osteodystrophy in asymptomatic hemodialysis patients: evidence of a sex-dependent distribution and predictive value of serum aluminum measurements.

von Herrath D, Asmus G, Pauls A, Delling G, Schaefer K. von Herrath D, et al. Am J Kidney Dis. 1986 Dec;8(6):430-5. doi: 10.1016/s0272-6386(86)80170-6. Am J Kidney Dis. 1986. PMID: 3812472

10

Renal osteodystrophy in pre-dialysis patients: ethnic difference?

Shin SK, Kim DH, Kim HS, Shin KT, Ma KA, Kim SJ, Kwak YS, Ha SK, Sherrard DJ. Shin SK, et al. Perit Dial Int. 1999;19 Suppl 2:S402-7. Perit Dial Int. 1999. PMID: 10406554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed